An observational study in Osteoporosis, sponsored by Beylikduzu State Hospital. Not yet recruiting. Open to female participants aged 50 Years to 59 Years. Per ClinicalTrials.gov, last updated 2025-07-01.
Sponsored by Beylikduzu State Hospital · Observational
This cross-sectional study will include postmenopausal women under the age of 60 who visited the Physical Medicine and Rehabilitation outpatient clinic at Beylikdüzü State Hospital between June 25 and July 25, 2025. Participants must have undergone a bone mineral density (BMD) assessment within the past six months using Dual X-ray Absorptiometry (DXA). Both osteoporotic and non-osteoporotic patients will be enrolled. Sociodemographic data such as age, height, weight, and BMI will be recorded. Femoral neck and L1-L4 T-scores and BMD values will be obtained from existing DXA results. Information on osteoporosis treatment, presence of fecal incontinence, constipation, and medication use will be collected. In the second phase, sarcopenia will be assessed according to EWGSOP2 criteria using bioelectrical impedance analysis for skeletal muscle mass, handgrip strength, and the five-time sit-to-stand test. Differences between the osteoporotic and non-osteoporotic groups will be analyzed.
1,640 studies on the registry are indexed under Osteoporosis; 212 are open to participants now.
This study's planned enrollment of 52 is below the median of 174 across 446 observational studies indexed under Osteoporosis.
Browse Osteoporosis studies →Beylikduzu State Hospital is the lead sponsor of 23 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Postmenopausal women under 60 years
Osteoporosis group: T-score ≤ -2.5 in femoral neck or L1-L4 region. Control group: T-score ≥ -1.0 in femoral neck and L1-L4 region.
-Patients who provide written informed consent to participate in the study.
Exclusion Criteria:
Skeletal Muscle Mass
Measured by bioelectrical impedance analysis (BIA), this assesses the amount of muscle tissue in the body. Low skeletal muscle mass indicates sarcopenia.
Time frame: 0 day
Handgrip Strength
This is a simple test to measure muscle strength. Reduced handgrip strength is a sign of sarcopenia.
Time frame: 0 day
5 times chair stand test
The Five Times Sit-to-Stand Test is a simple and widely used functional assessment tool to evaluate lower extremity muscle strength, balance, and mobility.
Time frame: 0 day
No study locations are listed for this record.
This study is not yet recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Beylikduzu State Hospital